Literature DB >> 17640816

Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain.

M F Poitras1, D W Koh, S-W Yu, S A Andrabi, A S Mandir, G G Poirier, V L Dawson, T M Dawson.   

Abstract

Poly(ADP-ribose) polymerases (PARPs) are members of a family of enzymes that utilize nicotinamide adenine dinucleotide (NAD(+)) as substrate to form large ADP-ribose polymers (PAR) in the nucleus. PAR has a very short half-life due to its rapid degradation by poly(ADP-ribose) glycohydrolase (PARG). PARP-1 mediates acute neuronal cell death induced by a variety of insults including cerebral ischemia, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism, and CNS trauma. While PARP-1 is localized to the nucleus, PARG resides in both the nucleus and cytoplasm. Surprisingly, there appears to be only one gene encoding PARG activity, which has been characterized in vitro to generate different splice variants, in contrast to the growing family of PARPs. Little is known regarding the spatial and functional relationships of PARG and PARP-1. Here we evaluate PARG expression in the brain and its cellular and subcellular distribution in relation to PARP-1. Anti-PARG (alpha-PARG) antibodies raised in rabbits using a purified 30 kDa C-terminal fragment of murine PARG recognize a single band at 111 kDa in the brain. Western blot analysis also shows that PARG and PARP-1 are evenly distributed throughout the brain. Immunohistochemical studies using alpha-PARG antibodies reveal punctate cytosolic staining, whereas anti-PARP-1 (alpha-PARP-1) antibodies demonstrate nuclear staining. PARG is enriched in the mitochondrial fraction together with manganese superoxide dismutase (MnSOD) and cytochrome C (Cyt C) following whole brain subcellular fractionation and Western blot analysis. Confocal microscopy confirms the co-localization of PARG and Cyt C. Finally, PARG translocation to the nucleus is triggered by NMDA-induced PARP-1 activation. Therefore, the subcellular segregation of PARG in the mitochondria and PARP-1 in the nucleus suggests that PARG translocation is necessary for their functional interaction. This translocation is PARP-1 dependent, further demonstrating a functional interaction of PARP-1 and PARG in the brain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640816      PMCID: PMC2000859          DOI: 10.1016/j.neuroscience.2007.04.062

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  69 in total

1.  Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death.

Authors:  Seong-Woon Yu; Shaida A Andrabi; Hongmin Wang; No Soo Kim; Guy G Poirier; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

2.  Poly(ADP-ribose) (PAR) polymer is a death signal.

Authors:  Shaida A Andrabi; No Soo Kim; Seong-Woon Yu; Hongmin Wang; David W Koh; Masayuki Sasaki; Judith A Klaus; Takashi Otsuka; Zhizheng Zhang; Raymond C Koehler; Patricia D Hurn; Guy G Poirier; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

3.  Poly(ADP-ribose) is required for spindle assembly and structure.

Authors:  Paul Chang; Myron K Jacobson; Timothy J Mitchison
Journal:  Nature       Date:  2004-12-02       Impact factor: 49.962

4.  NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1.

Authors:  Mi Young Kim; Steven Mauro; Nicolas Gévry; John T Lis; W Lee Kraus
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

5.  Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality.

Authors:  David W Koh; Ann M Lawler; Marc F Poitras; Masayuki Sasaki; Sigrid Wattler; Michael C Nehls; Tobias Stöger; Guy G Poirier; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-10       Impact factor: 11.205

Review 6.  The road to survival goes through PARG.

Authors:  David W Koh; Valina L Dawson; Ted M Dawson
Journal:  Cell Cycle       Date:  2005-03-24       Impact factor: 4.534

7.  Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase.

Authors:  Shunya Oka; Jiro Kato; Joel Moss
Journal:  J Biol Chem       Date:  2005-11-08       Impact factor: 5.157

8.  Activating the PARP-1 sensor component of the groucho/ TLE1 corepressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene activation pathway.

Authors:  Bong-Gun Ju; Derek Solum; Eun Joo Song; Kong-Joo Lee; David W Rose; Christopher K Glass; Michael G Rosenfeld
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

9.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia.

Authors:  M J Eliasson; K Sampei; A S Mandir; P D Hurn; R J Traystman; J Bao; A Pieper; Z Q Wang; T M Dawson; S H Snyder; V L Dawson
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

10.  Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death.

Authors:  Hongmin Wang; Seong-Woon Yu; David W Koh; Jasmine Lew; Carmen Coombs; William Bowers; Howard J Federoff; Guy G Poirier; Ted M Dawson; Valina L Dawson
Journal:  J Neurosci       Date:  2004-12-01       Impact factor: 6.167

View more
  18 in total

1.  The hypoxic preconditioning agent deferoxamine induces poly(ADP-ribose) polymerase-1-dependent inhibition of the mitochondrial respiratory chain.

Authors:  Ana Cañuelo; Rubén Martínez-Romero; Esther Martínez-Lara; José A Sánchez-Alcázar; Eva Siles
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

2.  PARP-1/PAR Activity in Cultured Human Lens Epithelial Cells Exposed to Two Levels of UVB Light.

Authors:  Caroline S Cencer; Shravan K Chintala; Tenira J Townsend; Daniel P Feldmann; Mirna A Awrow; Nahrain A Putris; Mason E Geno; Maria G Donovan; Frank J Giblin
Journal:  Photochem Photobiol       Date:  2017-09-15       Impact factor: 3.421

Review 3.  PARP and PARG inhibitors--new therapeutic targets in cancer treatment.

Authors:  Nilufer Jasmine Selimah Fauzee; Juan Pan; Ya-lan Wang
Journal:  Pathol Oncol Res       Date:  2010-04-12       Impact factor: 3.201

Review 4.  Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease.

Authors:  Joanna B Strosznajder; Grzegorz A Czapski; Agata Adamczyk; Robert P Strosznajder
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

Review 5.  Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases.

Authors:  Xueqing Ba; Nisha Jain Garg
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  Silencing Poly (ADP-Ribose) glycohydrolase (PARG) expression inhibits growth of human colon cancer cells in vitro via PI3K/Akt/NFκ-B pathway.

Authors:  Nilufer Jasmine Selimah Fauzee; Qiaozhuan Li; Ya-Lan Wang; Juan Pan
Journal:  Pathol Oncol Res       Date:  2011-06-30       Impact factor: 3.201

7.  Functional localization of two poly(ADP-ribose)-degrading enzymes to the mitochondrial matrix.

Authors:  Marc Niere; Stefan Kernstock; Friedrich Koch-Nolte; Mathias Ziegler
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

8.  Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity.

Authors:  Marianna N Rossi; Mariarosaria Carbone; Cassandra Mostocotto; Carmine Mancone; Marco Tripodi; Rossella Maione; Paolo Amati
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

9.  A specific isoform of poly(ADP-ribose) glycohydrolase is targeted to the mitochondrial matrix by a N-terminal mitochondrial targeting sequence.

Authors:  Clifford J Whatcott; Mirella L Meyer-Ficca; Ralph G Meyer; Myron K Jacobson
Journal:  Exp Cell Res       Date:  2009-04-21       Impact factor: 3.905

Review 10.  Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Cardiovasc Drug Rev       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.